Class II
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
- Recall number
- D-0677-2026
- Report date
- July 22, 2026
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Padagis US LLC
- Generic names
- NYSTATIN
- Brand names
- NYSTATIN
- Product NDCs
- 45802-059
Code and lot information
Lot #: 205060, Exp 09/30/2027
Distribution
USA Nationwide
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on July 28, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.